Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.  The facility will be built in Silicon Valley and bring Lilly’s lab expertise closer to the center of artificial intelligence innovation, Nvidia said on Monday. The company described the project as a joint investment, without elaborating on the financial terms. Bloomberg's Sam Fazeli joins to discuss. (Source: Bloomberg)